FDA permits marketing of device to help reduce opioid withdrawal symptoms
On Nov. 15, the U.S. Food and Drug Administration (FDA) granted a new indication to an electric stimulation device (NSS-2 Bridge) for use in helping to reduce the…
Please share your feedback! We’re interested to learn more about your experience with American Nurse Journal.